Morgan Stanley Maintains Equal-Weight on Elanco Animal Health, Raises Price Target to $26

Benzinga Newsdesk www.benzinga.com Positive 59.7%

Neg 0% Neu 0% Pos 59.7%

Morgan Stanley analyst Erin Wright maintains Elanco Animal Health (NYSE:ELAN) with a Equal-Weight and raises the price target from $23 to $26.